Log in to save to my catalogue

A third SARS-CoV-2 mRNA vaccine dose in people receiving hemodialysis overcomes B cell defects but e...

A third SARS-CoV-2 mRNA vaccine dose in people receiving hemodialysis overcomes B cell defects but e...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_2711092189

A third SARS-CoV-2 mRNA vaccine dose in people receiving hemodialysis overcomes B cell defects but elicits a skewed CD4+ T cell profile

Publication information

Publisher

Cold Spring Harbor: Cold Spring Harbor Laboratory Press

More information

Scope and Contents

Contents

Cellular immune defects associated with suboptimal responses to SARS-CoV-2 mRNA vaccination in people receiving hemodialysis (HD) are poorly understood. We longitudinally analyzed antibody, B cell, CD4+ and CD8+ T cell vaccine responses in 27 HD patients and 26 low-risk control individuals (CI). The first two doses elicit weaker B cell and CD8+ T c...

Alternative Titles

Full title

A third SARS-CoV-2 mRNA vaccine dose in people receiving hemodialysis overcomes B cell defects but elicits a skewed CD4+ T cell profile

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_journals_2711092189

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_2711092189

Other Identifiers

E-ISSN

2692-8205

DOI

10.1101/2022.09.05.506622